Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses

S. StenlerKarolinska Cell Therapy Center, Karolinska University Hospital, Stockholm, Sweden

K. E. LundinDepartment of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Huddinge, Sweden

L. HansenDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

S. PetkovDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

N. MozafariDepartment of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Huddinge, Sweden

M. IsaguliantsDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

P. BlombergKarolinska Cell Therapy Center, Karolinska University Hospital, Stockholm, Sweden

C. I. E. SmithDepartment of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Huddinge, Sweden

D. M. GoldenbergImmunomedics, Inc., Morris Plains, NJ, USA;IBC Pharmaceuticals, Inc., Morris Plains, NJ, USA

C.-H. ChangImmunomedics, Inc., Morris Plains, NJ, USA;IBC Pharmaceuticals, Inc., Morris Plains, NJ, USA

K. LjungbergDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

J. HinkulaDepartment of Molecular Virology, Linköping University, Linköping, Sweden

B. WahrenDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.